Review of Molecular Profiling-Real Time Polymerase Chain Reaction (Rt-Pcr) in Unknown Primary Cancer
Completed
- Conditions
- Unknown Primary Cancer
- Registration Number
- NCT00876408
- Lead Sponsor
- SCRI Development Innovations, LLC
- Brief Summary
This will be a retrospective review of 30 patients with unknown primary cancer who have had commercially available RT-PCR assays performed on biopsied tumors, in order to determine if the assay results are consistent with clinical features and useful for planning initial therapy or changing therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Patients with RT-PCR testing completed since commercialization of the RT-PCR assay in 2007.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To correlate the tissue of origin predicted by the RT-PCR assay with clinical and pathologic features of patients with carcinoma of unknown primary site. 6 months
- Secondary Outcome Measures
Name Time Method To correlate the tissue of origin predicted by the RT-PCR with actual primary sites found subsequently in a subset of patients. 6 months To evaluate the utility of RT-PCR assay results in guiding treatment selection in patients with carcinoma of unknown primary site. 6 months
Trial Locations
- Locations (1)
Tennessee Oncology, PLLC
🇺🇸Nashville, Tennessee, United States